IBO (Impact BioMedical, Inc.) Stock Analysis - AI Report
Impact BioMedical, Inc. (IBO) is a publicly traded Healthcare sector company. As of May 21, 2026, IBO trades at $0.53 with a market cap of $58.04M and a P/E ratio of -1.52. IBO moved +4.03% today. Year to date, IBO is +3.30%; over the trailing twelve months it is -3.03%. Its 52-week range spans $0.36 to $6.17. Rallies surfaces IBO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on IBO?
Rallies AI research for IBO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
Macko Todd D sold 43.40K (~$24.37K) on Mar 27, 2026.
Macko Todd D sold 1.60K (~$961.28) on Mar 25, 2026.
Grady Jason sold 50.00K (~$32.51K) on Mar 23, 2026.
IBO Analyst Consensus
IBO analyst coverage data. Average price target: $0.00.
Common questions about IBO
What is the AI research view on IBO?
Rallies AI research for IBO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for IBO?
Rallies AI research for IBO combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is IBO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IBO. It does not provide personalized investment advice.
